Industry News

Galderma’s Alastin Enters China

This is the first launch to feature Alastin by Galderma’s new re-energized, premium look and feel, a bold evolution that reflects its leadership in perioperative skincare, officials said.

Author Image

By: Lianna Albrizio

Associate Editor

Galderma has launched four core Alastin products in China, marking the premium medical skincare brand’s debut in one of the world’s fastest growing aesthetic skincare markets.

This is the first launch to feature Alastin by Galderma’s new re-energized, premium look and feel, a bold evolution that reflects its leadership in perioperative skincare, officials said.

“With Alastin by Galderma, we have a comprehensive perioperative solution to enhance skin recovery around aesthetic treatment and maintenance programs that bring together Galderma’s leading expertise in Dermatological Skincare and Injectable Aesthetics,” Alan D. Widgerow, chief scientific officer, Galderma, Head Skin Science Center for Innovation. “As the Asia-Pacific region’s beauty and aesthetics market continues to grow at pace, we’re proud to bring Alastin to patients in China who are seeking advanced solutions to support them in their aesthetic journeys.”

China’s Medical Aesthetics Market Grows

China’s medical aesthetics market is projected to increase by up to 15% in the next decade. As aesthetic treatments become increasingly mainstream, there is rising demand for perioperative skincare, with consumers willing to invest in advanced technologies and premium products to achieve optimal aesthetic outcomes. With its proven efficacy and full-spectrum approach to pre- and post-procedure care, as well as at-home maintenance, Alastin by Galderma is uniquely positioned to address this need.

“We’re seeing an incredible rise in demand for aesthetic procedures in China, and with that comes a growing need for effective perioperative skincare,” said Professor Yang Bin, Dermatology Hospital of Southern Medical University, China. “Alastin by Galderma brings a scientifically advanced approach to skin recovery, and I’m excited to see Chinese patients gain access to products that can truly support their skin before and after treatment, and elevate their overall results.”

The launch marks a decade of innovation with Alastin and follows strong growth in North America, Latin America, Australia, the UK and Ireland.

Keep Up With Our Content. Subscribe To Happi Newsletters